Inverness Medical Closes Cholestech Acquisition

Diagnostic test-maker Inverness Medical Innovations Inc. has completed a $326 million acquisition of a California competitor. Waltham, Mass.-based Inverness (AMEX: IMA) said on Wednesday that it had closed the stock deal to acquire Cholestech Corp. (Nasdaq: CTEC) through the merger of one of its wholly-owned subsidiaries with and into Cholestech. Cholestech’s shareholders approved the deal during a meeting on Wednesday. Inverness sells diagnostics tests in areas including infectious disease, cardiology, oncology, drug-abuse testing and women’s health. Cholestech makes cholesterol tests and other medical diagnostic tests. Inverness in recent months has gone on a buying spree. The company announced in August that it would buy HemoSense (AMEX: HEM) to access its diagnostic products to test for blood clotting. The company is also buying San Diego-based Biosite and Quality Assured Services Inc., a Florida company that provides diagnostic home test and services. SOURCE: Boston Business Journal

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics